NHS England Board Meeting 30 November 2017
- Extract from minutes:
- "Horizon scanning for new technologies - The Committee received an outline of the current tools used to understand the pharmaceutical pipeline, and the estimate of likely financial impact on specialised commissioning.”
- The following points were made in discussion:
- The Committee recognised the progress that had been made and discussed how the approach might be augmented to provide greater quantification of future pipeline.
- The issue of how to create a similar approach for medical technology devices and diagnostics was raised. It was agreed that a paper on this would be brought back to a future discussion.
- The Committee discussed the need to be able to compare the effectiveness of multiple drugs for the same indication. It was agreed that NHS England would explore the possibility of this approach with NIHR and NICE.
- It was concluded that further work would need to be conducted to model longer horizon periods (eg 2-3 years) to see the longer-term financial impact of the pharmaceutical pipeline."
